首页> 美国卫生研究院文献>Scientific Reports >A protein scaffold engineered SPINK2 for generation of inhibitors with high affinity and specificity against target proteases
【2h】

A protein scaffold engineered SPINK2 for generation of inhibitors with high affinity and specificity against target proteases

机译:一种蛋白支架经过工程改造的SPINK2可产生对靶蛋白酶具有高亲和力和特异性的抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Proteases are one of attractive therapeutic targets to play key roles in pharmacological action. There are many protease inhibitors in nature, and most of them structurally have cystine knot motifs. Their structures are favorable for recognition of active pockets of proteases, leading to the potent inhibition. However, they also have drawbacks, such as broad cross-reactivity, on the therapeutic application. To create therapeutic proteins derived from a disulfide-rich scaffold, we selected human serine protease inhibitor Kazal type 2 (SPINK2) through a scaffold screening, as a protein scaffold with requirements for therapeutic proteins. We then constructed a diverse library of the engineered SPINK2 by introducing random mutations into its flexible loop region with the designed method. By phage panning against four serine proteases, we isolated potent inhibitors against each target with picomolar KD and sub-nanomolar Ki values. Also, they exhibited the desired specificities against target proteases without inhibiting non-target proteases. The crystal structure of kallikrein related peptidase 4 (KLK4)-engineered SPINK2 complex revealed the interface with extensive conformational complementarity. Our study demonstrates that engineered SPINK2 can serve as a scaffold to generate therapeutic molecules against target proteins with groove structures.
机译:蛋白酶是在药理作用中起关键作用的有吸引力的治疗靶标之一。自然界中有许多蛋白酶抑制剂,其中大多数在结构上都具有胱氨酸结基序。它们的结构有利于识别蛋白酶的活性口袋,从而导致有效的抑制作用。然而,它们在治疗应用上也具有缺点,例如广泛的交叉反应性。为了创建衍生自富含二硫键的支架的治疗蛋白,我们通过支架筛选选择了人丝氨酸蛋白酶抑制剂Kazal 2型(SPINK2),作为对治疗蛋白有要求的蛋白支架。然后,我们通过设计的方法将随机突变引入其灵活的环区中,从而构建了工程化SPINK2的多样化文库。通过针对四种丝氨酸蛋白酶的噬菌体淘选,我们分离了针对具有皮摩尔KD和亚纳摩尔Ki值的每个靶标的有效抑制剂。而且,它们对靶蛋白酶表现出所需的特异性,而不抑制非靶蛋白酶。激肽释放酶相关肽酶4(KLK4)-工程的SPINK2复合物的晶体结构揭示了具有广泛构象互补性的界面。我们的研究表明,经过工程改造的SPINK2可以作为支架来产生针对具有沟结构的靶蛋白的治疗分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号